Skip to main content
. 2025 Jan 15;15:2084. doi: 10.1038/s41598-024-84247-w

Table 4.

Results of base case analysis.

Treatment Total cost($) QALY Incremental cost ($) Incremental QALY ICER ($/QALY)
Dacarbazine 10895.558 0.533
Eribulin 16961.891 0.698 6066.333 0.165 36736.467